Salarius: 3Q Earnings Snapshot

November 13, 2019 GMT

BOSTON (AP) _ Salarius Pharmaceuticals, Inc. (SLRX) on Wednesday reported a loss of $2.6 million in its third quarter.

The Boston-based company said it had a loss of 73 cents per share. Losses, adjusted for non-recurring gains and to account for discontinued operations, came to $1.04 per share.

The biotech drug developer posted revenue of $874,900 in the period. Its adjusted revenue was $875,000.

Salarius shares have fallen 33% since the beginning of the year. The stock has decreased 53% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SLRX at https://www.zacks.com/ap/SLRX